BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38447446)

  • 1. The investigation on sialic acid-modified pectin nanoparticles loaded with oxymatrine for orally targeting and inhibiting the of ulcerative colitis.
    Zhao C; Yang X; Fan M; Tian L; Sun T; Sun C; Jiang T
    Colloids Surf B Biointerfaces; 2024 Apr; 236():113809. PubMed ID: 38447446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
    Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
    AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.
    Chen X; Yu S; Wang P; Zhao X; Sang G
    Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.
    Zhang W; Zhang X; Lv X; Qu A; Liang W; Wang L; Zhao P; Wu Z
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
    Ahmed O; Abdel-Halim M; Farid A; Elamir A
    Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
    Zhou X; Liu Y; Wang X; Li X; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema.
    Dong K; Deng SJ; He BY; Guo ZY; Guan ZL; Leng X; Ma RR; Wang DY; Xing JF; You CY
    Drug Des Devel Ther; 2023; 17():191-207. PubMed ID: 36718245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
    Dong K; Zhang Y; Ji HR; Guan ZL; Wang DY; Guo ZY; Deng SJ; He BY; Xing JF; You CY
    Int J Nanomedicine; 2024; 19():993-1016. PubMed ID: 38299194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles.
    Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B
    Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.
    Luo R; Lin M; Fu C; Zhang J; Chen Q; Zhang C; Shi J; Pu X; Dong L; Xu H; Ye N; Sun J; Lin D; Deng B; McDowell A; Fu S; Gao F
    Carbohydr Polym; 2021 Jul; 263():117998. PubMed ID: 33858583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
    Wu M; Ping H; Wang K; Ding H; Zhang M; Yang Z; Du Q
    Int J Pharm; 2023 Nov; 647():123510. PubMed ID: 37839497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
    Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
    AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
    Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
    Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.
    Zhang Y; Ma R; You C; Leng X; Wang D; Deng S; He B; Guo Z; Guan Z; Lei H; Yu J; Zhou Q; Xing J; Dong Y
    Carbohydr Polym; 2023 Aug; 313():120884. PubMed ID: 37182972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
    Xiong M; Li Y; He H; Hao S; Fang P; Xu M; Chen Y; Chen Y; Yu S; Hu H
    Eur J Pharm Biopharm; 2023 Aug; 189():152-164. PubMed ID: 37336365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis.
    Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F
    Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis.
    Yan Y; Sun Y; Wang P; Zhang R; Huo C; Gao T; Song C; Xing J; Dong Y
    Carbohydr Polym; 2020 Oct; 246():116660. PubMed ID: 32747292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.